Pfizer Data Scientist at a Glance
Total Compensation
$112k - $310k/yr
Interview Rounds
5 rounds
Difficulty
Levels
G7 - G11
Education
PhD
Experience
0–18+ yrs
Most candidates from tech backgrounds walk into Pfizer interviews ready to talk about model architectures and deployment pipelines. They're caught off guard when the bulk of the conversation centers on data integrity, regulatory audit trails, and whether they can explain a Kaplan-Meier curve to a medical director who doesn't care about your code. From hundreds of mock interviews we've run, the single biggest prep mistake is treating this like a standard tech data science role when it's really a clinical data management and study deliverables role that happens to use Python.
Pfizer Data Scientist Role
Primary Focus
Skill Profile
Math & Stats
HighStrong applied statistics expected, including study design/analysis and core inferential methods (e.g., GLMs, mixed models, experimental design, quality control). For clinical data science/management roles, statistical rigor is important but may be less central than data integrity and standards; overall expectation remains high based on Pfizer data scientist/statistician postings.
Software Eng
MediumEmphasis on building automated statistical/data solutions and working end-to-end across the workflow (ingestion/cleaning/modeling/validation/insight delivery). Not explicitly heavy on large-scale application engineering practices in the provided sources; estimate is conservative.
Data & SQL
MediumExpected comfort with reliable data pipelines and data ingestion/cleaning; clinical context stresses data management deliverables, documentation, standards, and dataset release quality. Likely moderate hands-on pipeline work rather than dedicated data engineering ownership (uncertain).
Machine Learning
MediumML is included as part of the role toolkit (supervised/unsupervised methods, feature engineering, evaluation), with some roles expecting application to scientific problems; however, for clinical data scientist/management tracks the focus may tilt to data integrity/standards over advanced ML.
Applied AI
LowAI topics (e.g., NLP, image analysis) are mentioned in preferred qualifications for some data science roles, but generative AI specifically is not evidenced in the provided sources. Score reflects limited explicit requirement (uncertain).
Infra & Cloud
LowNo explicit cloud/deployment requirements in the provided sources. Work appears more analytics/statistical computing and regulated data management systems usage than MLOps/cloud deployment (uncertain).
Business
HighStrong cross-functional collaboration and stakeholder alignment expected; ability to connect analyses to scientific/business decisions in a regulated environment and communicate tradeoffs/impact is repeatedly emphasized.
Viz & Comms
HighClear written/verbal communication is required; ability to explain analyses to non-technical partners and deliver insights is emphasized. Visualization tools are explicitly referenced in clinical data contexts (e.g., Spotfire, jReview).
What You Need
- Applied statistical analysis (descriptive/inferential), model selection and evaluation
- Data cleaning, handling missing data, exploratory data analysis
- SQL for data access/analysis (explicitly emphasized in interview expectations)
- Python and/or R and/or SAS for analysis (SAS/R/Python cited)
- End-to-end analytics workflow discipline: validation, documentation, explainability
- Clinical/regulated environment rigor: data integrity, auditability, SOP/process adherence (especially for clinical data science/management)
- Cross-functional stakeholder communication and collaboration
Nice to Have
- Machine learning applications (supervised/unsupervised), feature engineering, optimization frameworks
- NLP, image analysis, high-dimensional data analysis (role-dependent)
- Experimental design and quality control methods
- Statistical/quantitative consulting or internal education/training experience
- Domain knowledge in biology/chemistry/pharmacology/toxicology or clinical trials (role-dependent)
- Vendor/CRO oversight and project/risk management in clinical data settings (role-dependent)
Languages
Tools & Technologies
Want to ace the interview?
Practice with real questions.
At Pfizer, a data scientist sits inside Clinical Data & Information Sciences, not a product analytics team. Your work supports clinical trial datasets, validation queries, and analyses that contribute to regulatory submissions for the FDA and EMA, though how directly depends on your level and therapeutic area. Success after year one looks different by grade: at G7 or G8, it means you've independently delivered well-scoped analyses, your code has survived a biostatistics peer review, and a therapeutic area lead recognizes you as someone who understands the data well enough to trust your outputs.
A Typical Week
A Week in the Life of a Pfizer Data Scientist
Typical L5 workweek · Pfizer
Weekly time split
Culture notes
- Pfizer operates at a large-pharma pace — weeks are structured around regulatory timelines and study milestones rather than sprint velocity, and most people work roughly 8:45 to 5:30 with limited after-hours expectations unless a filing deadline is imminent.
- The company follows a hybrid model requiring roughly three days per week in-office at Hudson Yards or the relevant site, with Tuesdays and Fridays being the most common remote days for deep focus work.
Documentation eats more of your week than coding does. TFL specifications, methodology write-ups, data handling decision logs: these are the artifacts an FDA auditor reviews years later, and Pfizer's data integrity SOPs demand every imputation choice and exclusion criterion be traceable. If you're coming from a startup where "ship it" was the mantra, the regulatory rigor here will feel like a different profession.
Projects & Impact Areas
Safety signal detection in oncology trials is a major workstream, where you might run disproportionality analyses on MedDRA-coded adverse events and reconcile WHO-Drug dictionary versions before biostatistics pulls a snapshot. Biomarker subgroup analysis is where the work gets intellectually interesting: exploring whether a PD-L1 expression threshold predicts differential response in a combination therapy arm, with messy lab data that demands careful imputation decisions documented to Pfizer's reproducibility standards. Underneath both sits the unglamorous backbone of QC pipeline work for CDISC-formatted datasets, automated reconciliation between EDC exports and derived analysis tables that keeps submissions on track.
Skills & What's Expected
SQL is the single most important technical skill Pfizer tests for, and candidates consistently underprepare for it. The role also expects fluency in SAS alongside Python and R, since SAS remains a first-class validation language in Pfizer's clinical data workflow. Machine learning carries a medium weight here: useful for patient stratification or biomarker discovery, but interviewers care more about whether you can design a sensitivity analysis for a covariate disagreement with the biostatistics team than whether you can tune a gradient boosting model.
Levels & Career Growth
Pfizer Data Scientist Levels
Each level has different expectations, compensation, and interview focus.
$100k
$5k
$7k
What This Level Looks Like
Executes well-scoped analytics and modeling work on a defined product, study, or business process area; impact is primarily at the project or sub-process level with limited cross-team influence; decisions are reviewed by more senior data scientists.
Day-to-Day Focus
- →Data wrangling and data quality
- →Solid statistical foundations and experimental thinking
- →Model evaluation and interpretability over novelty
- →Reproducible analysis (Python/R/SQL, Git) and documentation
- →Stakeholder communication and requirement clarification
Interview Focus at This Level
Emphasizes core statistics/ML fundamentals, SQL and data manipulation, practical Python/R coding, problem decomposition, and communicating insights from ambiguous-but-bounded prompts; expects familiarity with common metrics, validation approaches, and careful handling of healthcare/life-science data privacy considerations.
Promotion Path
Promotion to the next level typically requires demonstrating consistent independent delivery on end-to-end analyses, stronger problem framing with minimal supervision, measurable impact on a team’s KPIs or study deliverables, improved engineering/reproducibility practices, and credible stakeholder ownership for a small project or workstream.
Find your level
Practice with questions tailored to your target level.
The promotion blocker from G8 to G9 isn't modeling sophistication, it's demonstrated experience supporting regulatory submissions and leading cross-functional work. Pfizer also offers rotational programs (Digital Rotational and R&D Rotational) that may give early-career hires exposure to different therapeutic areas like oncology, vaccines, and rare disease, though their applicability to the Clinical Data Sciences track specifically isn't guaranteed.
Work Culture
Pfizer runs on regulatory timelines, not sprint velocity. Weeks feel structured around study milestones and filing deadlines, with most people working roughly 8:45 to 5:30 and limited after-hours pressure unless a submission is imminent. The hybrid model requires on-site presence roughly 2.5 days per week (commuting distance required), and candidates report that Tuesdays and Fridays tend to be the most common remote days for deep focus work.
Pfizer Data Scientist Compensation
The widget tells you the split. What it can't show is how lopsided that split feels compared to tech offers. Because so much of Pfizer's package sits in base salary, your year-one cash is predictable but your upside ceiling is lower. Equity grants exist at every level, though the specifics of vesting schedules and refresh grant cadence aren't publicly documented, so ask your recruiter for the plan details before you model out multi-year comp.
The single biggest negotiation lever most candidates overlook is pushing for a higher grade placement rather than a higher base within a lower grade. Moving up one grade resets your bonus target percentage, stock grant tier, and long-term promotion trajectory all at once. Base salary within the band and sign-on bonuses tend to be the most flexible line items, while bonus percentages are more standardized by grade. If you have competing offers from other pharma companies, name them explicitly, and anchor your ask on scope, domain expertise (CDISC fluency, causal inference, production analytics), and any one-time payments like relocation or sign-on before you accept.
Pfizer Data Scientist Interview Process
5 rounds·~3 weeks end to end
Initial Screen
2 roundsRecruiter Screen
First, a brief recruiter conversation focuses on whether your background matches the role and team needs. Expect questions on your data science experience in healthcare/biopharma contexts, core tools (Python/SQL), work authorization, and compensation expectations. You’ll also be evaluated on clarity, motivation for Pfizer, and basic fit with the role’s scope.
Tips for this round
- Prepare a 60–90 second pitch linking your projects to pharma use cases (clinical trials, RWE, manufacturing, commercial analytics).
- Be ready to name your strongest stack (e.g., Python/pandas, scikit-learn, SQL, Databricks/AWS) and one concrete impact metric per project.
- Clarify your preferred domain (RWE, clinical development, supply chain, commercial) and the type of stakeholders you’ve supported.
- Have a compensation range in mind and ask what components apply (base, annual bonus, sign-on, relocation).
- Confirm logistics early: location expectations, hybrid policy, start date, and interview timeline to reduce delays.
Hiring Manager Screen
Next, the hiring manager will dig into your end-to-end workflow and how you translate ambiguous questions into analyses and decisions. The conversation usually blends project deep-dives with practical tradeoffs (data quality, bias, validation, interpretability) and how you collaborate cross-functionally. You should expect some situational prompts aligned to Pfizer’s values (Excellence, Courage, Equity, Joy).
Technical Assessment
2 roundsSQL & Data Modeling
Expect a live SQL-focused session where you work through realistic data extraction and metric definitions. You may be asked to reason about joins, window functions, deduping, and building analysis-ready tables from messy real-world or trial-like datasets. The interviewer is typically looking for correctness, edge-case handling, and clean, explainable query structure.
Tips for this round
- Practice window functions (ROW_NUMBER, LAG/LEAD) and cohorting patterns (first event, exposure windows, censoring-style cutoffs).
- Talk through assumptions about grain and keys; explicitly state how you avoid double counting with one-to-many joins.
- Use CTEs to structure logic and annotate tricky parts (filters, time windows, eligibility).
- Validate outputs by sanity checks (row counts before/after joins, distinct IDs, null-rate checks).
- Be ready to sketch a simple schema (facts/dimensions) and justify indexing/partitioning choices conceptually.
Statistics & Probability
In this round, the interviewer will probe your statistical reasoning and how you make trustworthy inferences from noisy healthcare or business data. You’ll likely field questions on hypothesis testing, confidence intervals, bias/variance, missing data, and study design tradeoffs. Some roles will lean into real-world evidence style thinking such as confounding, selection bias, and treatment effect estimation.
Onsite
1 roundBehavioral
Finally, you’ll typically meet 3–5 colleagues (including the hiring manager) in a sequence of one-on-ones or a panel, often around 45 minutes each. Expect behavioral and situational prompts aligned to Excellence, Courage, Equity, and Joy, plus role-relevant follow-ups that test how you operate in cross-functional, high-integrity environments. This stage also checks communication style, stakeholder management, and whether you can deliver accurate, explainable work under real constraints.
Tips for this round
- Prepare 6–8 STAR stories mapped to values (think big, focus on what matters, speak up, inclusion/equity, resilience, quality).
- Highlight explainability and decision impact: how you wrote narratives, built dashboards, or influenced a scientific/business call.
- Demonstrate collaboration habits: requirement docs, analytics plans, review cycles, and how you handle disagreements with evidence.
- Anticipate ethics/data integrity questions (privacy, governance, reproducibility) and have a concrete example of doing the “right” thing under pressure.
- Keep energy consistent across interviews by using a structured close: summarize your fit in 30 seconds and ask one tailored question per interviewer.
Tips to Stand Out
- Anchor your stories to Pfizer’s values. Build a small library of STAR examples explicitly tied to Excellence, Courage, Equity, and Joy; label the value out loud and connect it to outcomes and behaviors.
- Show end-to-end data science, not just modeling. Emphasize ingestion/cleaning, feature definitions, validation, monitoring, and how insights were delivered (docs, dashboards, stakeholder readouts).
- Be meticulous about data integrity and explainability. In pharma contexts, reviewers care about reproducibility, assumptions, and auditability; narrate checks for leakage, bias, and quality gates.
- Practice “scenario-driven” case communication. Rehearse how you’d respond to ambiguous prompts by clarifying the goal, defining success metrics, proposing an analysis plan, and outlining risks.
- Make your SQL and statistics crisp. Expect practical queries and applied inference; drill window functions, cohort definitions, confounding pitfalls, and how you’d validate results.
- Manage the timeline proactively. Candidate reports sometimes mention slow updates; set expectations with the recruiter, ask for next steps, and send concise follow-ups after each round.
Common Reasons Candidates Don't Pass
- ✗Weak practical translation. Strong theory but inability to turn a business/scientific question into a concrete dataset, metric definition, and analysis plan comes across as low execution readiness.
- ✗Gaps in statistical rigor. Hand-wavy inference, misunderstanding uncertainty, or ignoring confounding/multiple comparisons can be a red flag in regulated, high-stakes decision settings.
- ✗Unclear communication and stakeholder handling. Overly technical explanations without a clear takeaway, or difficulty aligning with cross-functional partners, often leads to “not a fit” feedback.
- ✗Poor SQL fundamentals or sloppy edge cases. Incorrect joins, double counting, or inability to reason about grain/time windows signals risk when working with RWE/clinical-like data.
- ✗Limited evidence of values alignment. Struggling to provide examples of speaking up, prioritizing what matters, or inclusive collaboration can hurt in structured behavioral scoring.
Offer & Negotiation
For Data Scientist roles at a large pharma like Pfizer, offers commonly include base salary plus an annual performance bonus; equity/long-term incentives may be more common at senior levels than entry/mid, and sign-on or relocation can appear depending on scarcity and location. The most negotiable levers are typically base (within band), sign-on bonus, relocation support, and level/title alignment; annual bonus percentage is often more standardized by grade. Negotiate by anchoring on scope and level (impact, domain expertise in RWE/clinical, and scarce skills like causal inference or production analytics), and ask for the full breakdown plus any one-time payments before accepting.
The most common reason candidates wash out, from what's reported, is failing to translate a clinical question into a concrete analysis plan. Pfizer's hiring manager screen specifically probes whether you can take something like "Did Braftovi reduce progression in this colorectal cancer cohort?" and map it to a dataset, an endpoint definition, a statistical approach, and the CDISC tables you'd pull from. Vague answers about "building models" without touching data integrity, visit windows, or regulatory constraints signal you haven't worked in a submission-grade environment.
Pfizer's behavioral panel (3 to 5 interviewers, including the hiring manager) scores you against their Courage, Excellence, Equity, and Joy values. Because each conversation is a separate evaluation, you can't afford an off round. Have at least six STAR stories ready, mapped to different values, so you're not scrambling to fit one anecdote to every prompt.
Pfizer Data Scientist Interview Questions
Applied Biostatistics & Clinical Trial Analysis
Expect questions that force you to choose and justify statistical methods used in clinical development (e.g., GLMs, mixed models, multiplicity, missing data) under real trial constraints. Candidates often struggle when asked to translate assumptions and endpoints into analysis choices that stand up to review.
In a Phase 3 vaccine trial with a time-to-first symptomatic infection endpoint, how do you justify using a Cox model versus a Poisson model for vaccine efficacy, and what diagnostics do you run to defend proportional hazards to reviewers?
Sample Answer
Most candidates default to a Cox model, but that fails here because you still need to defend proportional hazards and align the estimand with surveillance and case accrual. You use Cox when hazard ratios are interpretable for the estimand and censoring is non-informative, then check proportional hazards via Schoenfeld residuals, log-minus-log plots, and time-varying covariate tests. If PH is violated, you pre-specify alternatives like stratified Cox, piecewise Cox, or RMST and explain how that changes interpretation. You also validate event definitions and risk windows from EDC to avoid immortal time bias.
Your primary endpoint is change from baseline in $\mathrm{HbA1c}$ at Week 24 with visits at Weeks 4, 12, and 24, and dropout depends on prior outcome. Which primary analysis do you propose, and how do you justify missing data assumptions under ICH E9(R1)?
In a Phase 2 dose-ranging study with 4 active doses plus placebo and two key secondary endpoints, how do you control multiplicity while preserving power, and what do you say when clinical wants to "just report nominal $p$-values"?
Clinical Data Management, Integrity & Regulatory Compliance (GCP/ICH)
Most candidates underestimate how much rigor is expected around data provenance, auditability, and SOP-driven deliverables in a regulated environment. You’ll be tested on how you would prevent, detect, and document data issues across the EDC-to-database-to-analysis workflow.
In a Pfizer Phase 3 study run in Medidata Rave, you find that for a subset of subjects the EDC audit trail shows post-lock edits to dosing dates. What deliverables and controls do you require before allowing the data into the analysis datasets and TFLs?
Sample Answer
You require documented impact assessment plus controlled remediation evidence before analysis use. You confirm the database lock status, identify every impacted record via audit trail extract, and quantify downstream impact on derived variables and endpoints. You require a deviation note or quality issue record, documented approvals (Data Management, Clinical, Statistics), and an updated, versioned data cut with traceable lineage into ADaM and TFL outputs.
A CRO delivers a new SDTM transfer for a Pfizer oncology trial, but your prior transfer already fed a key interim analysis and the new one contains changes in AE coding (MedDRA) and several date imputations. How do you decide whether to accept the transfer, and what evidence do you produce to stay inspection-ready under ICH E6?
SQL for Clinical Data Retrieval & QC
Your ability to pull the right patient-level and visit-level slices quickly is a core signal, especially for data cleaning and reconciliation tasks. Interviewers commonly probe joins, window functions, and anomaly checks that mirror clinical data listings and QC.
In an EDC export aligned to SDTM, return one row per subject with their latest non-missing systolic blood pressure (SBP) from VS, including visit name and collection date, and flag subjects with no SBP recorded.
Sample Answer
You could do a correlated subquery to pick the max VS date per subject or use a window function to rank rows. The window function wins here because it is clearer, handles ties deterministically, and is easier to extend for QC flags and additional columns without turning into nested queries.
1/*
2Assumed schema (typical SDTM-like):
3 dm(usubjid)
4 vs(usubjid, visit, vsdtc, vstestcd, vsorres, vsstat)
5Goal:
6 - latest non-missing SBP per subject
7 - include visit and date
8 - flag subjects with no SBP
9Notes:
10 - Treat VSSTAT = 'NOT DONE' as missing
11 - Prefer numeric parsing for VSORRES when possible
12*/
13WITH sbp AS (
14 SELECT
15 v.usubjid,
16 v.visit,
17 CAST(v.vsdtc AS DATE) AS vsdt,
18 TRY_CAST(v.vsorres AS DECIMAL(10,2)) AS sbp_value,
19 ROW_NUMBER() OVER (
20 PARTITION BY v.usubjid
21 ORDER BY CAST(v.vsdtc AS DATE) DESC, v.visit DESC
22 ) AS rn
23 FROM vs v
24 WHERE v.vstestcd = 'SYSBP'
25 AND (v.vsstat IS NULL OR UPPER(v.vsstat) <> 'NOT DONE')
26 AND v.vsorres IS NOT NULL
27), latest_sbp AS (
28 SELECT
29 usubjid,
30 visit,
31 vsdt,
32 sbp_value
33 FROM sbp
34 WHERE rn = 1
35)
36SELECT
37 d.usubjid,
38 l.vsdt AS latest_sbp_date,
39 l.visit AS latest_sbp_visit,
40 l.sbp_value AS latest_sbp_value,
41 CASE WHEN l.usubjid IS NULL THEN 1 ELSE 0 END AS missing_sbp_flag
42FROM dm d
43LEFT JOIN latest_sbp l
44 ON l.usubjid = d.usubjid
45ORDER BY d.usubjid;For a Pfizer Phase 3 study, build a QC listing to detect duplicate MedDRA coding in AE: same subject, same start date, and same preferred term coded to multiple PT codes, return the conflicting code sets with counts.
Stakeholder Communication & Cross-Functional Decision Support
The bar here isn't whether you can run analyses, it's whether you can align with ClinOps, biostats, safety, and vendors while communicating risk and tradeoffs clearly. You’ll need crisp narratives for data issues, timeline impact, and defensible recommendations.
A Phase 3 study in Medidata Rave shows a sudden spike in protocol deviations at 5 sites right after a mid-study EDC edit-check update, and ClinOps wants to freeze the database anyway. How do you brief ClinOps, biostats, and the study physician in 10 minutes so they can decide whether to pause, proceed with mitigation, or delay DB lock?
Sample Answer
Reason through it: Walk through the logic step by step as if thinking out loud. Start by separating signal from artifact, confirm whether the spike aligns exactly with the edit-check release and whether the definition of deviation changed. Quantify impact in decision terms, how many subjects, what endpoints, what windows, and whether deviations are major per SAP definitions. Offer options with tradeoffs, proceed with targeted data review and site retraining while keeping DB lock date, or delay DB lock to prevent a known bias, and state the residual risk and documentation plan for GCP auditability.
Safety sees a $30\%$ increase in MedDRA-coded 'hepatic enzyme increased' after a new WHO-Drug version and coding convention were rolled out, and they suspect a real safety signal. How do you structure the cross-functional conversation with safety, medical coding, and biostats to decide whether this is coding drift or a true increase in incidence?
A CRO delivers SDTM and ADaM, but your checks show $8\%$ of key efficacy visits have missing dates and biostats says imputation could change the primary estimand under ICH E9(R1). How do you recommend a path forward to the clinical team and vendor, including what gets documented and what gets deferred, without blowing the submission timeline?
Python/R/SAS Analytics Coding (Data Wrangling, Validation, Reproducibility)
Rather than trivia, you’ll be evaluated on whether you can turn messy clinical-style tables into analysis-ready outputs with checks, logs, and repeatable code. Common pitfalls include handling missingness correctly, defining populations/flags, and writing verifiable transformations.
You receive an EDC export with DM and AE tables for a Pfizer trial; build an analysis-ready subject-level table with SAFETYFL (has any dose), TRTSDT (first dose date), and TEAEFL (any AE with AESTDT on or after TRTSDT), and produce a validation report of excluded or inconsistent records (missing USUBJID, AE dates before informed consent, duplicate dosing dates).
Sample Answer
This question is checking whether you can translate clinical definitions into deterministic flags, then prove your transforms are correct with explicit checks and counts. You need to keep merges lossless, document assumptions (for example, date parsing and partial dates), and surface data issues instead of silently dropping rows. Expect scrutiny on join keys, deduping rules, and whether your validation output is reproducible and auditable.
1import pandas as pd
2import numpy as np
3from dataclasses import dataclass
4from typing import Dict, Tuple
5
6# ----------------------------
7# Utilities
8# ----------------------------
9
10def to_datetime_safe(s: pd.Series) -> pd.Series:
11 """Parse dates robustly; invalid parses become NaT."""
12 return pd.to_datetime(s, errors='coerce', utc=False)
13
14
15def require_columns(df: pd.DataFrame, cols, df_name: str) -> None:
16 missing = [c for c in cols if c not in df.columns]
17 if missing:
18 raise ValueError(f"{df_name} is missing required columns: {missing}")
19
20
21def normalize_usubjid(df: pd.DataFrame) -> pd.DataFrame:
22 """Standardize USUBJID type and whitespace."""
23 out = df.copy()
24 if 'USUBJID' in out.columns:
25 out['USUBJID'] = out['USUBJID'].astype(str).str.strip()
26 out.loc[out['USUBJID'].isin(['', 'nan', 'None']), 'USUBJID'] = np.nan
27 return out
28
29
30# ----------------------------
31# Core transform
32# ----------------------------
33
34def build_subject_level(dm: pd.DataFrame,
35 ae: pd.DataFrame,
36 ex: pd.DataFrame,
37 expected_ae_date_col: str = 'AESTDT',
38 expected_ic_date_col: str = 'RFICDT') -> Tuple[pd.DataFrame, Dict[str, pd.DataFrame]]:
39 """Create subject-level flags and a validation report.
40
41 Inputs expected (minimal):
42 DM: USUBJID, RFICDT (informed consent date)
43 EX: USUBJID, EXSTDTC (dose start date) or EXSTDT
44 AE: USUBJID, AESTDT (AE start date)
45
46 Returns:
47 adsl_like: subject-level dataset
48 report: dict of issue tables
49 """
50
51 dm = normalize_usubjid(dm)
52 ae = normalize_usubjid(ae)
53 ex = normalize_usubjid(ex)
54
55 # Required columns
56 require_columns(dm, ['USUBJID'], 'DM')
57 require_columns(ex, ['USUBJID'], 'EX')
58 require_columns(ae, ['USUBJID'], 'AE')
59
60 # Choose dose date column
61 dose_date_col = None
62 for c in ['EXSTDT', 'EXSTDTC', 'EXSTDATE', 'EXSTDTM']:
63 if c in ex.columns:
64 dose_date_col = c
65 break
66 if dose_date_col is None:
67 raise ValueError('EX needs a dose date column such as EXSTDT or EXSTDTC')
68
69 # Parse dates
70 dm = dm.copy()
71 ex = ex.copy()
72 ae = ae.copy()
73
74 if expected_ic_date_col in dm.columns:
75 dm['RFICDT_parsed'] = to_datetime_safe(dm[expected_ic_date_col])
76 else:
77 dm['RFICDT_parsed'] = pd.NaT
78
79 ex['EXSTDT_parsed'] = to_datetime_safe(ex[dose_date_col])
80
81 # Allow fallback for AE date column naming
82 ae_date_col = expected_ae_date_col if expected_ae_date_col in ae.columns else None
83 if ae_date_col is None:
84 for c in ['AESTDT', 'AESTDTC', 'AESTDATE', 'AESTDTM']:
85 if c in ae.columns:
86 ae_date_col = c
87 break
88 if ae_date_col is None:
89 raise ValueError('AE needs an AE start date column such as AESTDT or AESTDTC')
90 ae['AESTDT_parsed'] = to_datetime_safe(ae[ae_date_col])
91
92 # Validation tables
93 report: Dict[str, pd.DataFrame] = {}
94
95 # Missing USUBJID in any domain
96 miss_dm = dm[dm['USUBJID'].isna()].assign(DOMAIN='DM')
97 miss_ex = ex[ex['USUBJID'].isna()].assign(DOMAIN='EX')
98 miss_ae = ae[ae['USUBJID'].isna()].assign(DOMAIN='AE')
99 report['missing_usubjid'] = pd.concat([miss_dm, miss_ex, miss_ae], ignore_index=True)
100
101 # Duplicate dosing dates per subject
102 ex_nonnull = ex.dropna(subset=['USUBJID', 'EXSTDT_parsed'])
103 dup_dose = (
104 ex_nonnull
105 .groupby(['USUBJID', 'EXSTDT_parsed'])
106 .size()
107 .reset_index(name='n')
108 .query('n > 1')
109 .sort_values(['USUBJID', 'EXSTDT_parsed'])
110 )
111 report['duplicate_dose_dates'] = dup_dose
112
113 # AE dates before informed consent (RFICDT)
114 dm_rfic = dm[['USUBJID', 'RFICDT_parsed']].dropna(subset=['USUBJID'])
115 ae_w_rfic = ae.merge(dm_rfic, on='USUBJID', how='left')
116 ae_before_ic = ae_w_rfic[
117 ae_w_rfic['AESTDT_parsed'].notna() &
118 ae_w_rfic['RFICDT_parsed'].notna() &
119 (ae_w_rfic['AESTDT_parsed'] < ae_w_rfic['RFICDT_parsed'])
120 ][['USUBJID', ae_date_col, 'AESTDT_parsed', expected_ic_date_col if expected_ic_date_col in dm.columns else 'RFICDT_parsed', 'RFICDT_parsed']]
121 report['ae_before_informed_consent'] = ae_before_ic
122
123 # Compute TRTSDT = first dose date
124 trtsdt = (
125 ex.dropna(subset=['USUBJID', 'EXSTDT_parsed'])
126 .groupby('USUBJID', as_index=False)['EXSTDT_parsed']
127 .min()
128 .rename(columns={'EXSTDT_parsed': 'TRTSDT'})
129 )
130
131 # SAFETYFL: has any dose (non-missing TRTSDT)
132 # TEAEFL: any AE with AESTDT on/after TRTSDT
133 adsl = dm.dropna(subset=['USUBJID']).drop_duplicates(subset=['USUBJID']).copy()
134 adsl = adsl.merge(trtsdt, on='USUBJID', how='left')
135 adsl['SAFETYFL'] = np.where(adsl['TRTSDT'].notna(), 'Y', 'N')
136
137 # TEAE computation
138 ae_for_teae = ae.dropna(subset=['USUBJID']).merge(trtsdt, on='USUBJID', how='left')
139 teae_by_subj = (
140 ae_for_teae
141 .assign(is_teae=lambda d: d['AESTDT_parsed'].notna() & d['TRTSDT'].notna() & (d['AESTDT_parsed'] >= d['TRTSDT']))
142 .groupby('USUBJID', as_index=False)['is_teae']
143 .any()
144 .rename(columns={'is_teae': 'TEAE_any'})
145 )
146 adsl = adsl.merge(teae_by_subj, on='USUBJID', how='left')
147 adsl['TEAE_any'] = adsl['TEAE_any'].fillna(False)
148 adsl['TEAEFL'] = np.where(adsl['TEAE_any'], 'Y', 'N')
149
150 # Add summary counts for reproducibility, as a compact validation log
151 summary = pd.DataFrame({
152 'metric': [
153 'n_dm_subjects',
154 'n_ex_records',
155 'n_ae_records',
156 'n_subjects_dosed',
157 'n_subjects_teae',
158 'n_missing_usubjid_rows',
159 'n_duplicate_dose_date_pairs',
160 'n_ae_before_informed_consent'
161 ],
162 'value': [
163 adsl['USUBJID'].nunique(),
164 len(ex),
165 len(ae),
166 int((adsl['SAFETYFL'] == 'Y').sum()),
167 int((adsl['TEAEFL'] == 'Y').sum()),
168 len(report['missing_usubjid']),
169 len(report['duplicate_dose_dates']),
170 len(report['ae_before_informed_consent'])
171 ]
172 })
173 report['summary'] = summary
174
175 # Keep only essential columns for an ADSL-like output
176 keep_cols = ['USUBJID', 'TRTSDT', 'SAFETYFL', 'TEAEFL']
177 if expected_ic_date_col in dm.columns:
178 keep_cols.insert(1, expected_ic_date_col)
179 adsl_out = adsl[[c for c in keep_cols if c in adsl.columns]].copy()
180
181 return adsl_out, report
182
183
184# Example usage (expects dm, ae, ex dataframes already loaded):
185# adsl, report = build_subject_level(dm, ae, ex)
186# print(report['summary'])
187Given AE and WHO-Drug coded CM (concomitant meds) exports, write a reproducible Python function that standardizes MedDRA PT and WHO-Drug ATC text (case, whitespace, common synonyms), then validates that no PT or ATC codes are lost during standardization and that join keys used for an integrated safety table are one-to-one at the intended grain (USUBJID, AETERM, AESTDT).
Applied Machine Learning for Clinical Data (Model Choice, Metrics, Interpretation)
When ML appears, it usually targets practical judgment: selecting models, evaluating performance, and explaining limitations on small, noisy, biased clinical datasets. You’ll be expected to discuss interpretability, leakage, and validation strategy more than fancy architectures.
You are building a model to flag potentially underreported serious adverse events from EDC data (demographics, labs, visit schedule, MedDRA-coded AEs) across multiple Pfizer studies. Which model family and validation split do you choose to minimize leakage across sites and patients, and what interpretation output do you provide to clinical ops so they can act on it?
Sample Answer
The standard move is a regularized logistic regression or gradient-boosted trees with a group-aware split (by patient, often also by site or study) and probability calibration. But here, leakage and distribution shift matter because the same site workflows and patient follow-up patterns can appear in both train and test, inflating AUC while failing on a new study. Provide ranked risk with calibrated probabilities plus top drivers (SHAP or monotone coefficients) and stability checks across studies, not just a single global feature importance.
You train a time-to-event model to predict treatment discontinuation using longitudinal labs and vitals, updated at each visit, and you report C-index and AUC at 24 weeks. How do you define the prediction time origin, handle censoring and competing risks, and choose metrics so the model is interpretable and does not use future information from later visits?
What jumps out isn't any single category but how the questions layer on top of each other. A SQL round might ask you to pull adverse event records from an SDTM schema, then the biostatistics round asks you to model those same events with a Cox regression, and the regulatory round asks what happens when a CRO delivers revised data after your analysis is locked. Candidates who prep each topic in isolation miss that Pfizer interviewers evaluate whether you can move fluidly across that full chain. The biggest misallocation of study time, from what candidates report: spending weeks on gradient boosting and neural net architectures while barely skimming ICH E9 or CDISC data structures.
Drill Pfizer-relevant clinical trial scenarios and cross-functional communication questions at datainterview.com/questions.
How to Prepare for Pfizer Data Scientist Interviews
Know the Business
Official mission
“Breakthroughs that change patients’ lives.”
What it actually means
Pfizer's real mission is to apply scientific innovation and global resources to discover, develop, and manufacture medicines and vaccines that significantly improve and extend patients' lives, while also working to expand access to affordable healthcare worldwide.
Key Business Metrics
$63B
-1% YoY
$154B
+0% YoY
81K
-8% YoY
Current Strategic Priorities
- Reduce drug costs for millions of Americans
- Ensure affordability for American patients while preserving America’s position at the forefront of medical innovation
- Expand PfizerForAll to offer more ways for people to be in charge of their health care
- Bring therapies to people that extend and significantly improve their lives
- Advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time
Competitive Moat
Pfizer reported $62.6 billion in revenue last year, down slightly, while trimming headcount by about 8% to 81,000 employees. Where the company is loudly spending energy: a cost-savings program called TrumPRx aimed at lowering drug costs for millions of Americans, the PfizerForAll digital health expansion, and pipeline wins like Braftovi's progression-free survival results in colorectal cancer.
For a data scientist, that mix of affordability pressure and active clinical programs shapes your day-to-day more than any ML trend. Expect your analyses to feed regulatory submissions and pricing narratives, not recommendation engines.
Most candidates fumble the "why Pfizer" question by saying they want to "use data science to help patients." That's table stakes at any pharma company. Anchor your answer to something only Pfizer is doing right now. Survival analysis background? Name the oncology pipeline and Braftovi specifically. Built data quality frameworks before? Talk about scaling CDISC compliance across a portfolio that's actively growing through acquisitions. Worked on access or affordability modeling? Reference TrumPRx by name and explain what your skills add to that program.
Try a Real Interview Question
EDC data quality: find subjects with overdue unresolved queries
sqlGiven EDC query data, return one row per subject with $n_{overdue}$ equal to the count of unresolved queries where $days\_open = DATEDIFF(day, opened\_dt, as\_of\_dt)$ is at least $14$, and $max\_days\_open$ as the maximum $days\_open$ among those overdue unresolved queries. Output columns: study\_id, subject\_id, n\_overdue, max\_days\_open, sorted by $n_{overdue}$ descending then $max\_days\_open$ descending.
| query_id | study_id | subject_id | opened_dt | closed_dt | status |
|---|---|---|---|---|---|
| Q1 | S100 | SUBJ01 | 2024-01-01 | NULL | Open |
| Q2 | S100 | SUBJ01 | 2024-01-10 | 2024-01-20 | Closed |
| Q3 | S100 | SUBJ02 | 2024-01-05 | NULL | Answered |
| Q4 | S200 | SUBJ03 | 2024-01-02 | NULL | Open |
| study_id | as_of_dt |
|---|---|
| S100 | 2024-01-25 |
| S200 | 2024-01-20 |
| S300 | 2024-02-01 |
700+ ML coding problems with a live Python executor.
Practice in the EngineFrom what candidates report, Pfizer's SQL round leans on clinical data scenarios (joining adverse event tables to treatment arms, flagging missing visit windows) rather than algorithm puzzles. Drill these patterns at datainterview.com/coding, paying special attention to window functions over patient visit sequences and QC flag logic for derived datasets.
Test Your Readiness
How Ready Are You for Pfizer Data Scientist?
1 / 10Can you choose and justify an appropriate statistical method for a time-to-event endpoint in a randomized clinical trial, including how you would check proportional hazards and what you would do if the assumption fails?
If you're coming from outside pharma, read ICH E9 and skim the CDISC SDTM implementation guide before testing yourself at datainterview.com/questions. That weekend of reading closes the single biggest gap between your current knowledge and what Pfizer's interview process expects.
Frequently Asked Questions
How long does the Pfizer Data Scientist interview process take?
Most candidates report the Pfizer Data Scientist process taking 4 to 8 weeks from application to offer. You'll typically go through a recruiter screen, a technical phone screen, and then a virtual or onsite loop. Pharma hiring can move slower than tech companies, so don't panic if there are gaps between rounds. I've seen some candidates wait 2+ weeks between the technical screen and the final loop, especially when hiring managers are juggling clinical timelines.
What technical skills are tested in a Pfizer Data Scientist interview?
SQL is non-negotiable. Pfizer explicitly emphasizes it in their interview expectations, so expect to write queries under pressure. Beyond that, you need solid Python, R, or SAS skills for analysis, applied statistics (both descriptive and inferential), model selection and evaluation, and data cleaning including handling missing data. The pharma context also means they care about data integrity, auditability, and documentation. If you can't explain your validation process clearly, that's a red flag for them.
How should I tailor my resume for a Pfizer Data Scientist role?
Lead with quantifiable impact from your analytics or modeling work. Pfizer operates in a regulated clinical environment, so any experience with data integrity, SOPs, or auditable workflows should be front and center. Mention specific tools (Python, SQL, R, SAS) by name since their job descriptions call these out explicitly. If you've worked cross-functionally with non-technical stakeholders, highlight that too. Pfizer values collaboration, and your resume should reflect it. Keep it to one page for G7/G8 roles, two pages max for G9+.
What is the total compensation for a Pfizer Data Scientist?
Pfizer uses a grade-level system. At G7 (junior, 0-2 years experience), total comp averages around $112,000 with a base of $100,000. G8 (mid-level, 3-6 years) jumps to about $165,000 TC on a $145,000 base. Senior G9 roles (4-8 years) average $195,000 TC. Staff-level G10 (8-14 years) hits around $250,000, and Principal G11 (10-18 years) can reach $310,000 or higher. The ranges are wide, so location and negotiation matter. A G8 in New York could land closer to $210,000 while one in a lower cost-of-living area might be near $135,000.
How do I prepare for the Pfizer behavioral interview?
Pfizer's core values are Courage, Excellence, Equity, and Joy. You should have at least one story ready for each. They want to hear about times you pushed back on a bad approach (Courage), delivered rigorous work under pressure (Excellence), ensured fair or inclusive outcomes (Equity), and brought energy to a team (Joy). Use the STAR format but keep it tight. I'd spend 60-90 seconds per answer max. Cross-functional collaboration stories play especially well here since pharma data scientists work closely with clinicians, regulatory teams, and business stakeholders.
How hard are the SQL questions in Pfizer Data Scientist interviews?
For G7 and G8 roles, expect medium-difficulty SQL. Think multi-table joins, window functions, aggregation with HAVING clauses, and filtering on date ranges. Nothing that requires obscure syntax, but you need to be fast and accurate. At G9 and above, the questions get more applied. You might need to write queries that handle messy real-world scenarios like duplicate records or missing values. Practice on datainterview.com/coding to get comfortable with the style and time pressure.
What machine learning and statistics concepts does Pfizer test?
Applied statistics is the backbone. Expect questions on hypothesis testing, confidence intervals, regression (linear and logistic), and experiment design. For ML, they focus on practical model selection, bias-variance tradeoffs, feature engineering, and validation strategies like cross-validation. At senior levels (G9+), you'll face deeper questions on causal inference, confounding, and how to handle data quality issues in regulated environments. They care less about cutting-edge deep learning and more about whether you can pick the right method and defend why. Practice these concepts at datainterview.com/questions.
What is the best format for answering Pfizer behavioral interview questions?
STAR works well here. Situation, Task, Action, Result. But honestly, the key at Pfizer is emphasizing the 'why' behind your decisions. They want to see judgment, not just execution. Keep each answer under two minutes. Start with a one-sentence setup, spend most of your time on what you actually did, and close with a measurable result. If you don't have a number for the result, at least describe the business or scientific outcome. Avoid vague answers like 'I collaborated with the team.' Be specific about your individual contribution.
What happens during the Pfizer Data Scientist onsite or final round interview?
The final loop typically includes 3 to 5 sessions. You'll face a technical deep dive (SQL, Python/R coding, and applied stats), a case-style problem where you frame an analytics approach to a business or scientific question, and at least one behavioral round. For senior roles (G9+), expect a presentation or walkthrough of a past project where interviewers probe your end-to-end thinking: problem framing, data strategy, model choices, validation, and deployment. Cross-functional communication skills get evaluated throughout every session, not just the behavioral one.
What business metrics and domain concepts should I know for a Pfizer Data Scientist interview?
Pfizer is a pharma company with $62.6B in revenue, so understanding clinical trial phases, patient outcomes, and drug development timelines helps a lot. You should know basic concepts like efficacy vs. effectiveness, adverse event monitoring, and what regulatory data requirements look like at a high level. For commercial-side roles, be ready to discuss patient segmentation, market access, and prescription volume trends. You don't need to be a domain expert, but showing you understand the stakes of working with clinical data (integrity, auditability, compliance) will set you apart.
What are common mistakes candidates make in Pfizer Data Scientist interviews?
The biggest one I see is treating it like a pure tech interview. Pfizer operates in a regulated environment, so jumping straight to a fancy model without discussing data validation, documentation, or explainability is a miss. Another common mistake is being vague about your statistical reasoning. Saying 'I used random forest because it works well' won't cut it. They want to hear about tradeoffs, assumptions, and why you chose one approach over another. Finally, don't skip the stakeholder communication angle. If you can't explain your results to a non-technical audience, that's a problem at Pfizer.
What education do I need to get hired as a Pfizer Data Scientist?
For G7 (junior) roles, a BS in computer science, statistics, math, engineering, or a related quantitative field is the baseline. An MS is preferred but not required. At G8 and G9, a BS/MS is standard, and a PhD is sometimes preferred for research-heavy positions. For G10 and G11 (staff and principal), an MS or PhD is strongly preferred, though equivalent industry experience can substitute. Pfizer's pharma context means degrees in biostatistics or bioinformatics carry extra weight, but they're not mandatory if your applied experience is strong.


